Literature DB >> 16371782

Adenoviral keratoconjunctivitis in a tertiary care eye clinic.

Amir Latif Butt1, James Chodosh.   

Abstract

PURPOSE: To elucidate the natural history and epidemiology of adenoviral keratoconjunctivitis as seen in a tertiary care eye clinic.
METHODS: In a retrospective observational case series design, the medical records of 54 consecutive patients seen over a 6-year period at the Dean McGee Eye Institute (DMEI) with a diagnosis of adenoviral keratoconjunctivitis were analyzed retrospectively. The main outcome measure was the duration of symptomatic subepithelial corneal infiltrates following onset of acute conjunctivitis.
RESULTS: Annual case numbers ranged from 3 each in 1997 and 1998 to 26 in 2000. No more than 5 new cases presented in any single month, and no seasonal predominance was evident. The median duration of disease was 5 weeks, but the mean was 23.4 weeks, reflecting a subset of patients with a prolonged course. Indeed, 14 (25.9%) of 54 patients demonstrated symptomatic subepithelial corneal infiltrates for more than 45 days from the first examination for conjunctivitis.
CONCLUSION: These data suggest a significant level of long-term morbidity for adenoviral keratoconjunctivitis.

Entities:  

Mesh:

Year:  2006        PMID: 16371782     DOI: 10.1097/01.ico.0000170693.13326.fb

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  34 in total

1.  Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis.

Authors:  Ashish V Chintakuntlawar; James Chodosh
Journal:  Ocul Immunol Inflamm       Date:  2010-10       Impact factor: 3.070

Review 2.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

3.  Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.

Authors:  L Asena; E Şıngar Özdemir; A Burcu; E Ercan; M Çolak; D D Altınörs
Journal:  Eye (Lond)       Date:  2017-02-03       Impact factor: 3.775

4.  Novel model of innate immunity in corneal infection.

Authors:  Jaya Rajaiya; Xiaohong Zhou; Irina Barequet; Michael S Gilmore; James Chodosh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-15       Impact factor: 2.416

5.  Protein Kinase C Signaling in Adenoviral Infection.

Authors:  Mohammad A Yousuf; Ji Sun Lee; Xiaohong Zhou; Mirja Ramke; Jeong Yoon Lee; James Chodosh; Jaya Rajaiya
Journal:  Biochemistry       Date:  2016-10-11       Impact factor: 3.162

Review 6.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

7.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis.

Authors:  Ashish V Chintakuntlawar; Xiaohong Zhou; Jaya Rajaiya; James Chodosh
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

9.  Resident corneal c-fms(+) macrophages and dendritic cells mediate early cellular infiltration in adenovirus keratitis.

Authors:  Mirja Ramke; Xiaohong Zhou; Emma Caroline Materne; Jaya Rajaiya; James Chodosh
Journal:  Exp Eye Res       Date:  2016-05-13       Impact factor: 3.467

10.  Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.

Authors:  Ashish V Chintakuntlawar; James Chodosh
Journal:  J Interferon Cytokine Res       Date:  2009-10       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.